CDIX Cardiff Lexington Corp
Services-Offices & Clinics of Doctors of Medicine · OTC · SEC CIK 811222 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.3%
TTM net income YoY-105.9%
TTM EPS YoY16.5%
Revenue 3-yr CAGR-1.8%
Net income 3-yr CAGR—
Margins
Gross margin60.4%
Operating margin-10.9%
Net margin-92.1%
FCF margin—
EBITDA margin-10.8%
Returns
ROE-749.4%
ROA-32.9%
ROIC (approx.)-4.7%
Asset turnover0.36x
Leverage & solvency
Liabilities / assets88.3%
Debt / equity12.95x
Current ratio0.91x
Interest coverage-0.14x
Cash quality & payout
Operating cash flow / net income0.17x
Accruals ratio-27.2%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $11.54M | $8.27M | $11.85M | $10.69M | $9.88M |
| Cost of revenue | $4.33M | $3.84M | $3.56M | $4.06M | $3.77M |
| Gross profit | $7.21M | $4.43M | $8.29M | $6.63M | $6.11M |
| SG&A expense | $5.33M | $4.06M | $3.08M | $2.70M | $4.43M |
| Operating income | $1.10M | -$193,504 | $5.20M | $3.91M | $1.66M |
| Interest expense | $6.82M | $3.05M | $439,618 | $452,864 | — |
| Pretax income | -$5.75M | -$3.19M | $3.11M | -$3.25M | -$303,612 |
| Income tax | $0 | — | — | — | — |
| Net income | -$5.51M | -$3.30M | $3.03M | -$5.43M | $666,293 |
| EBITDA | $1.11M | -$180,043 | $5.22M | $3.93M | $1.68M |
| EPS (basic) | — | — | — | — | -0.01 |
| EPS (diluted) | — | — | — | — | -0.01 |
| Weighted avg. shares (diluted) | 8.50M | 3.82M | 15,001 | 5,822 | 128.02M |
| Balance sheet | |||||
| Cash & equivalents | $318,535 | $1.19M | $866,943 | $219,085 | $580,968 |
| Receivables | $22.07M | $15.93M | $13.31M | $6.60M | $6.01M |
| Current assets | $22.59M | $17.21M | $14.18M | $6.83M | $6.59M |
| PP&E, net | $2,953 | $21,198 | $34,661 | $55,439 | $78,570 |
| Goodwill | $5.67M | $5.67M | $5.67M | $5.67M | $7.76M |
| Intangibles | — | — | — | — | $0 |
| Total assets | $29.09M | $23.93M | $20.75M | $13.34M | $15.30M |
| Current liabilities | $25.83M | $15.89M | $13.86M | $9.96M | $11.17M |
| Short-term debt | — | $3.62M | $87,460 | $2.49M | — |
| Long-term debt | $18.56M | $9.21M | $2.28M | $155,598 | $600,932 |
| Total debt | $18.56M | $12.83M | $2.37M | $2.65M | $600,932 |
| Total liabilities | $26.01M | $16.32M | $14.12M | $10.19M | $11.44M |
| Shareholders' equity | -$2.47M | $2.69M | $731,418 | -$1.74M | $486,840 |
| Net debt | $18.24M | $11.64M | $1.50M | $2.43M | $19,964 |
| Shares outstanding | 13.70M | 5.10M | 25,121 | 10,997 | 166.13M |
| Cash flow statement | |||||
| Operating cash flow | -$2.85M | -$2.77M | -$1.81M | -$1.15M | -$850,141 |
| Capital expenditure | — | — | — | $0 | $3,407 |
| Free cash flow | — | — | — | -$1.15M | -$853,548 |
| Investing cash flow | — | — | — | $0 | -$2.32M |
| Financing cash flow | $1.98M | $2.98M | $2.37M | $788,794 | $3.68M |
| Depreciation & amortization | $5,652 | $13,461 | $20,777 | $23,132 | $13,886 |
| Stock-based compensation | $754,475 | $544,725 | $0 | — | — |
| Dividends paid | $50,000 | $100,000 | — | — | — |
Free plan shows the latest 5 periods; Pro shows all 24 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.